2-(TOLUENE-4-SULFONYLAMINO)-BENZOIC ACID METHYL ESTER, 95.0%, 250mg

5-Bromooxindole, 98.0%, 1g

4-Bromo-5,6-dichloro-1H-indazole, 98%, 250mg

Di(p-methoxyphenyl)phenylphosphine, 97%, 1g

1-Methyl-1H-pyrazol-4-ylamine, 99.00%, 5g

Ethanone, 1-[5-(bromomethyl)-2-nitrophenyl]-, 95%, 100g

4-Amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one, 95.0%, 250mg

2,2'-Dipyridyl Disulfide [for Peptide Synthesis]>98.0%(GC)(T)25g

dimethyl sulfoxide, min 99.5%, for synthesis, 25 l, plastic packaging.

2-(Bis(3,5-di-tert-butylphenyl)phosphino)-N-((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)benzamide, 100mg

D-Homoserine Lactone hydrochloride, 95.0%, 10g

3-Amino-N,N-diethyl propionamide hydrochloride, 98.0%, 1g

2-Methyl-1-decene, 97.0%, 2g